Torslanda, Sweden

Anders Holmén


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Anders Holmén

Introduction

Anders Holmén is a notable inventor based in Torslanda, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work at AstraZeneca AB. His expertise and creativity have led to the development of valuable compounds that have potential applications in medicine.

Latest Patents

Holmén holds a patent for "Aminopropylphosphinic acids - Intermediates used in the preparation of compounds of formula I, or a stereoisomer thereof, or a pharmaceutically acceptable form of either selected from the group consisting of a salt, a solvate and a combination thereof, with the exception of i) the racemate of (3-amino-2-hydroxypropyl)phosphinic acid; and ii) (2R/S,3R)-(3-amino-2-hydroxybutyl)phosphinic acid." This patent highlights his innovative approach to creating intermediates that can be utilized in pharmaceutical formulations.

Career Highlights

Throughout his career, Holmén has demonstrated a strong commitment to advancing pharmaceutical research. His work at AstraZeneca AB has positioned him as a key player in the development of new therapeutic agents. With a total of 1 patent, he continues to contribute to the scientific community through his research and innovations.

Collaborations

Holmén has collaborated with esteemed colleagues such as Thomas Elebring and Peter Guzzo. These partnerships have fostered an environment of creativity and innovation, leading to advancements in their respective fields.

Conclusion

Anders Holmén's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in medicine. His work continues to inspire future advancements in drug development and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…